{"": [133, 1783, 0], "Introduction": [1784, 3582, 0], "Design of an accessible protein subunit vaccine": [3592, 7214, 0], "Immunogenicity testing in cynomolgus macaques": [7215, 9746, 0], "Challenge with SARS-CoV-2": [9747, 11629, 0], "Results": [3583, 11629, 1], "Discussion": [11630, 16537, 0], "Production of vaccine samples": [16561, 16837, 0], "Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE)": [16838, 18205, 0], "Competitive ELISA by ACE2-Fc binding": [18206, 19127, 0], "Production of unformulated drug substance": [19128, 19696, 0], "Biolayer interferometry": [19697, 20700, 0], "Negative-stain electron microscopy": [20701, 21335, 0], "Immunization of non-human primates": [21336, 22117, 0], "ELISA assays": [22118, 23370, 0], "Pseudovirus neutralization assays": [23371, 24944, 0], "ELISPOT assays": [24945, 26182, 0], "Viral load assays": [26183, 28041, 0], "Histopathology": [28042, 29291, 0], "Materials and Methods": [16538, 29291, 1], "Supplementary Material": [29292, 29318, 0]}